TESTOLONE

RAD-140

Description:

Puretech Testolone RAD 140 (SARMS) contains RAD 140, a non‑steroidal SARM designed to bind selectively to androgen receptors in muscle and bone while aiming to minimize stimulation of tissues such as the prostate. Preclinical models show potent anabolic effects on lean mass and bone, with tissue‑selective activity that differentiates it from traditional anabolic steroids. The product is presented as 20 mg capsules, 30 per bottle, intended for controlled research environments or advanced performance applications where such substances are legally permitted, not as an approved therapeutic.

Note: The points below reflect potential or investigated effects based on early and mainly preclinical data; they are not approved medical claims, and RAD 140 is not authorized as a treatment for any condition in most countries.

Demonstrates strong anabolic activity in animal studies, supporting increases in lean muscle mass and muscle strength with comparatively lower activity in reproductive tissues, suggesting a degree of tissue selectivity.
Shows beneficial effects on bone parameters and may help preserve or enhance bone mineral density in preclinical models, which has driven interest in conditions like muscle wasting and osteoporosis.
Exhibits neuroprotective properties in experimental systems, where RAD 140 has been shown to protect hippocampal neurons from toxic insults while activating androgen‑responsive pathways in the brain.

There is no established, regulatory‑approved dosing regimen for RAD 140 in humans; any use in people is experimental and not recommended outside formal trials or approved research protocols.
Puretech Testolone RAD 140 provides 20 mg per capsule; publicly discussed experimental protocols often reference once‑daily oral dosing in research contexts, but dose, cycle length, and washout periods must be defined by qualified professionals and must not be self‑determined.
If used within an authorized research setting, administration should follow a documented protocol with baseline and follow‑up monitoring of liver enzymes, lipids, hormones, hematology, and cardiovascular status.

RAD 140 is not approved for general human consumption; safety, long‑term toxicity, and interaction profiles remain poorly characterized, and medical and regulatory bodies warn against its recreational or unsupervised use.
Case reports and emerging data have linked RAD 140 and related SARMs to serious adverse effects, including liver injury, negative impacts on cardiovascular risk factors, suppression of endogenous testosterone, mood changes, and potential increases in frailty and mortality indicators in animal models.
As with other SARMs sold for performance enhancement, there is a significant risk of product mislabeling, contamination, and anti‑doping violations; this product should be kept out of reach of children and handled only where legally permitted and under expert oversight, not used as a substitute for approved medical therapies.

Puretech Testolone RAD 140 meets elite standards with third‑party verification of >98% purity, no solvents or residuals. GMP production ensures tablet‑to‑tablet consistency, while microbial and heavy metal screens confirm safety. Secure, light‑proof packaging keeps it potent—elite quality for elite results.